Ophthalmology· Topic 13.2 Progressive and acute vision loss: cataract, glaucoma, and retinal disease· 13.2.8

Amaurosis fugax

Amaurosis fugax is transient, painless monocular vision loss from retinal ischemia, most often microembolic from an ipsilateral carotid or a cardiac source, and it is treated as a TIA-equivalent with urgent carotid/cardiac workup and immediate aspirin 81 mg daily plus a high-intensity statin.

10 min read2 practice questions8 key factsSubscriber article
  • Topic review
    The full article, organized the way the exam asks it.
  • ABIM-format MCQs
    Vignettes with an explanation for every wrong answer.
  • Key facts
    The numbers and thresholds worth memorizing, up front.
  • AI tutor
    MedBrain answers the question you're stuck on.

What this article covers

  • Overview

    Definition: sudden, painless, transient monocular vision loss from temporary retinal ischemia, classically a curtain or shade descending over one eye that resolves completely within minutes.

  • Epidemiology

    Age and risk-factor overlap: occurs mainly over age 60, more common in men, with the atherosclerotic risk factors (hypertension, diabetes, hyperlipidemia, smoking) that drive ischemic stroke and TIA generally.

  • Risk factors

    Carotid atherosclerosis, age over 60 years: the dominant risk factor; risk rises with stenosis grade, substantial at 50% to 70% and highest above 70%.

  • Pathophysiology

    Embolic occlusion of the retinal circulation: a platelet-fibrin or cholesterol embolus, or less often a calcific valvular embolus, lodges in the central retinal artery or a branch, transiently interrupting flow.

  • Clinical features

    Sudden, painless, monocular vision loss: the hallmark; a curtain, shade, or gray-out over part or all of one eye's field, without pain.

  • Differential diagnosis

    Giant cell arteritis: transient or progressive loss with headache, scalp tenderness, jaw claudication, fever over age 50; discriminated by elevated ESR (typically 50 mm/h) and CRP, and threatens permanent, bilateral loss.

  • Diagnosis

    This is a clinical diagnosis established by history: sudden, painless, transient monocular vision loss lasting seconds to under an hour with complete resolution and a normal interval eye exam.

  • Management

    Treat as an emergency, urgent evaluation before discharge: same-day carotid imaging and cardiac assessment, because stroke risk is highest in the first 48 hours after a TIA; admission or an…

  • Complications

    Ischemic stroke: the principal risk; untreated patients face the same short-term stroke risk as any other TIA, concentrated in the first 48 hours to 90 days.

  • Prognosis

    Stroke risk mirrors TIA: highest in the first 48 hours and through 90 days, which is why urgent workup and immediate secondary prevention change outcomes.

  • Prevention

    Aspirin 81 mg PO once daily, continued indefinitely, for any history of amaurosis fugax or other atherosclerotic vascular event, as first-line secondary prevention.

Read the whole article

Subscribing to Internal Medicine opens every article, the full question bank and MedBrain, on the web, iPhone and Android.